XML 151 R77.htm IDEA: XBRL DOCUMENT v3.20.1
Stockholders' Equity (Options) (Details) - USD ($)
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2019
Nov. 03, 2014
Apr. 30, 2007
Stock options            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Balance at the end of the period (in shares) 1,880,846 1,953,334 2,179,787 1,880,846    
Number of options            
Balance at the beginning of period (in shares) 1,953,334 2,179,787        
Options granted (in shares) 0 0        
Options exercised (in shares) (51,451) (147,463)        
Options forfeited (in shares) (21,037) (78,990)        
Balance at the end of the period (in shares) 1,880,846 1,953,334 2,179,787      
Number of options vested and expected to vest (in shares)       1,880,846    
Number of options vested and exercisable (in shares)       1,794,439    
Weighted average exercise price            
Balance at the beginning of period (in dollars per share) $ 7.42 $ 7.60        
Options exercised (in dollars per share) 2.44 7.79        
Options forfeited (in dollars per share) 19.39 11.68        
Balance at the end of period (in dollars per share) $ 7.42 $ 7.42 $ 7.60      
Additional information            
Weighted average remaining contractual term 5 years 5 months 23 days 6 years 3 months 18 days 7 years 3 months 7 days      
Weighted average remaining contractual term, vested and exercisable 5 years 8 months 26 days          
Options granted (in shares) 0 0        
Weighted average grant date fair value (in dollars per share)     $ 4.54      
Stock-based compensation expense $ 600,000 $ 1,600,000 $ 2,200,000      
Number of years from the date of grant for tax benefits 2 years          
Number of years from the date of exercise for tax benefits 1 year          
Unrecognized compensation costs (in dollars)       $ 0    
Aggregate intrinsic value (in dollars) $ 600,000 $ 2,000,000 $ 3,100,000      
2007 Plan            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Common stock reserved for issuance (in shares)           1,690,448,000
Balance at the end of the period (in shares) 360,015,000     360,015,000    
Number of shares available for future grants       0    
Number of options            
Balance at the end of the period (in shares) 360,015,000          
2014 Plan            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Common stock reserved for issuance (in shares)       4,710,672,000 1,027,500,000  
Number of shares available for future grants       615,460,000    
Inducement Plan            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Number of shares available for future grants       217,379,000    
Number of shares awarded 1,294,949,000          
Grant period of stock awards 10 years          
Number of additional years of requisite service period 3 years          
Inducement Plan | Minimum            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Purchase price of awards expressed as a percentage of fair value of shares on the date of grant 100.00%          
Inducement Plan | Minimum | Individual options            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Vesting percentage 25.00%          
2007 Plan and 2014 Plan | Stock options            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Grant period of stock awards 10 years          
2007 Plan and 2014 Plan | Stock options | Minimum            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Purchase price of awards expressed as a percentage of fair value of shares on the date of grant 100.00%          
Percentage of voting power owned by shareholder       10.00%    
2007 Plan and 2014 Plan | Stock options | Maximum            
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]            
Purchase price of awards expressed as a percentage of fair value of shares on the date of grant 110.00%